Table 1 Distributions of neuroendocrine carcinoma by primary sites, Japan, 2009–2015
Sites | ALL | Male | Female | |||
|---|---|---|---|---|---|---|
Number | % | Number | % | Number | % | |
Lung | 5,465 | 31.3% | 4,626 | 26.5% | 839 | 4.8% |
Stomach | 2,256 | 12.9% | 1,813 | 10.4% | 443 | 2.5% |
Pancreas | 1,315 | 7.5% | 776 | 4.4% | 539 | 3.1% |
Rectum | 1,174 | 6.7% | 738 | 4.2% | 436 | 2.5% |
Esophagus | 1,019 | 5.8% | 783 | 4.5% | 236 | 1.3% |
Colon | 983 | 5.6% | 527 | 3.0% | 456 | 2.6% |
Cervix | 752 | 4.3% | 0.0% | 752 | 4.3% | |
Bladder | 577 | 3.3% | 430 | 2.5% | 147 | 0.8% |
Bile cystic duct | 480 | 2.7% | 243 | 1.4% | 237 | 1.4% |
Breast | 429 | 2.5% | 7 | 0.0% | 422 | 2.4% |
Prostate | 289 | 1.7% | 289 | 1.7% | 0.0% | |
Duodenum | 245 | 1.4% | 157 | 0.9% | 88 | 0.5% |
Others | 2,501 | 14.3% | 1,491 | 8.5% | 1,010 | 5.8% |
Total | 17,485 | 100.0% | 11,880 | 67.9% | 5,605 | 32.1% |